DrugPatentWatch Database Preview
Details for Patent: 8,143,239
Which drugs does patent 8,143,239 protect, and when does it expire?
Patent 8,143,239 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-nine patent family members in twenty-seven countries.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-nine patent family members in twenty-seven countries.
Summary for Patent: 8,143,239
| Title: | Composition for inhalation |
| Abstract: | The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000. |
| Inventor(s): | Govind; Nayna (Leicestershire, GB), Marlow; Maria (Leicestershire, GB) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) |
| Application Number: | 12/790,196 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Delivery; Use; |
Drugs Protected by US Patent 8,143,239
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 8,143,239
Non-Orange Book US Patents Family Members for Patent 8,143,239
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
International Patents Family Members for US Patent 8,143,239
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Slovenia | 1474117 | ➤ Sign Up | |||
| Sweden | 0200312 | ➤ Sign Up | |||
| Russian Federation | 2301673 | ➤ Sign Up | |||
| Russian Federation | 2004122921 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
